4//SEC Filing
SANDERS MACHELLE 4
Accession 0001127602-24-018846
CIK 0000882796other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:31 PM ET
Size
5.0 KB
Accession
0001127602-24-018846
Insider Transaction Report
Form 4
SANDERS MACHELLE
Director
Transactions
- Sale
Common Stock
2024-06-17$6.00/sh−4,689$28,134→ 27,742 total
Footnotes (2)
- [F1]These shares were sold with the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of 16,745 Restricted Stock Units on June 13, 2024.
- [F2]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $5.99 to $6.01. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001718020
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:31 PM ET
- Size
- 5.0 KB